The coronavirus pandemic has caused untold misery, pain and suffering, but it has also revolutionized how clinical trials for new drugs and treatments are carried out. When the pandemic first started in March 2020, clinical trials – like nearly everything else in New Jersey – came to a grinding halt as people were told to stay home. With work still needing to continue, clinical trials were forced to abruptly shift gears. Prior to the pandemic, clinical trials were run out of clinical research units at medical schools, doctors offices and other in-person locations, which involved participants traveling to brick-and-mortar study sites to be evaluated, said Dr. Reynold Panettieri, vice chancellor for translational medicine and science and director of the Rutgers University Institute for Translational Medicine and Science. To read the full story.